We have certainly had some interesting characters over the years.
Great to see
@DocMcstuffins pop by today saying that he hopes he is wrong, when that is all he has ever been! Hilarious.
@whytee was supposed to do a 12 month results with
@Lopez last week,to compare Mesoblast to Polynovo! Hilarious. Meso up 800% Pnv down 40%
Given the pricing announced today I can see the strategy re AA for CHF.
Rexlemestrocel gets priced on CHF mortality benefit first- CLBP BLA follows with a fraction of the cells but with benchmark pricing set in the more serious condition.
If we get the HLHS voucher- we will use it on CLBP. All my opinion, not investment advice
Reg
(20min delay)